US stock futures edge up and the dollar nears 3-week highs after minutes show the Fed still has appetite for rate hikes


Pressure BioSciences Announces Contract for October 2022 Launch of Breakthrough Hemp-Derived CBD Product, Estimating $2 Million Incremental 2023 Revenue

Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide nutraceuticals, biotechnology, cosmetics, and food & beverage industries, today announced the execution of a manufacturing, sales, and distribution agreement with Canopy CBD Farms, LLC (“CCF”), a Massachusetts licensed processor/manufacturer/distributor

Leave a Reply

Your email address will not be published. Required fields are marked *